This study has investigated the interaction of raised extracellular magnesium and agents which act via cAMP with respect to inhibition of platelet aggregation and effects on platelet cAMP accumulation.
Iloprost (3 ng/ml) and PGD2 (0.2 μg/ml) each caused time dependent increases in platelet cAMP which were significantly greater in the presence of 3 mM added MgS04 (p <0.01). Addition of ADP (5 μM) resulted in a fall in cAMP which remained higher in the presence of MgS04 (p <0.01).
Forskolin (5 μg/ml) and DN9693 (100 μM) also caused increments in platelet cAMP but these responses were not influenced by added MgS04. Addition of ADP resulted in a further increase in cAMP which was augmented by MgS04 (p <0.03). This increase was abolished by adenosine deaminase (1.2 U/ml).
These experiments show that MgS04 can modify the cAMP responses produced by iloprost and PGD2 and by forskolin and DN9693 when ADP is present. It appears that as well as inhibiting, ADP can also stimulate cAMP production under certain experimental conditions. This appears to be due to breakdown of ADP to adenosine.
References
1
Heptinstall S.
The use of a chelating ion-exchange resin to evaluate the effects of the extracellular calcium concentration on adenosine diphosphate induced aggregation of human blood platelets. Thromb Haemost 1976; 36i: 208-220
4
Hwang DL,
Yen CF,
Nadler JL.
Effect of extracellular magnesium on platelet activation and intracellular calcium mobilisation. Am J Hypertens 1992; 5: 700-706
5
Adams JH,
Mitchel JR A.
The effects of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thromb Haemost 1979; 42: 603-610
6
Gertz SD,
Wajnberg RS,
Kurgan A,
Uretzky G.
Effect of magnesium sulfate on thrombus formation following partial arterial constriction: Implications for coronary vasospasm. Magnesium 1987; 6: 225-235
10
Fox SC,
Burgess-Wilson M,
Heptinstall S,
Mitchell JR A.
Platelet aggregation in whole blood determined using the ultra-flo 100 platelet counter. Thromb Haemost 1982; 48: 327-329
11
Louden KA,
Broughton Pipkin F,
Heptinstall S,
Fox SC,
Mitchell JR A,
Symonds EM.
A longitudinal study of platelet behaviuor and thromboxane production in whole blood in normal pregnancy and the puerperium. Br J Obstet Gynaecol 1990; 97: 1108-1114
13
Horn EH,
Cooper J,
Hardy E,
Hcptinstall S,
Rubin PC.
A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Clin Sci 1991; 80: 549-558
14
Heptinstall S,
Bevan J,
Cockbill SR,
Hanley SP,
Parry MJ.
Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thromb Res 1980; 20: 219-230
21
Pritchard JA,
Cunningham EG,
Pritchard SA.
The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 1984; 148: 951-960
